HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of peripheral and mucosal immune responses in rhesus macaques on long-term tenofovir and emtricitabine combination antiretroviral therapy.

AbstractBACKGROUND:
The goal of antiretroviral therapy (ART) is to suppress virus replication to limit immune system damage. Some have proposed combining ART with immune therapies to boost antiviral immunity. For this to be successful, ART must not impair physiological immune function.
METHODS:
We studied the impact of ART (tenofovir and emtricitabine) on systemic and mucosal immunity in uninfected and simian immunodeficiency (SIV)-infected Chinese rhesus macaques. Subcutaneous ART was initiated 2 weeks after tonsillar inoculation with SIVmac239.
RESULTS:
There was no evidence of immune dysregulation as a result of ART in either infected or uninfected animals. Early virus-induced alterations in circulating immune cell populations (decreased central memory T cells and myeloid dendritic cells) were detected, but normalized shortly after ART initiation. ART-treated animals showed marginal SIV-specific T-cell responses during treatment, which increased after ART discontinuation. Elevated expression of CXCL10 in oral, rectal, and blood samples and APOBEC3G mRNA in oral and rectal tissues was observed during acute infection and was down regulated after starting ART. ART did not impact the ability of the animals to respond to tonsillar application of polyICLC with increased CXCL10 expression in oral fluids and CD80 expression on blood myeloid dendritic cells.
CONCLUSION:
Early initiation of ART prevented virus-induced damage and did not impede mucosal or systemic immune functions.
AuthorsEdith Jasny, Suzanne Geer, Ines Frank, Panagiotis Vagenas, Meropi Aravantinou, Andres M Salazar, Jeffrey D Lifson, Michael Piatak Jr, Agegnehu Gettie, James L Blanchard, Melissa Robbiani
JournalJournal of acquired immune deficiency syndromes (1999) (J Acquir Immune Defic Syndr) Vol. 61 Issue 4 Pg. 425-35 (Dec 01 2012) ISSN: 1944-7884 [Electronic] United States
PMID22820802 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Anti-Retroviral Agents
  • Organophosphonates
  • Deoxycytidine
  • Tenofovir
  • Emtricitabine
  • Adenine
Topics
  • Adenine (administration & dosage, analogs & derivatives)
  • Animals
  • Anti-Retroviral Agents (administration & dosage)
  • Antiretroviral Therapy, Highly Active (methods)
  • Deoxycytidine (administration & dosage, analogs & derivatives)
  • Emtricitabine
  • Immunity, Mucosal
  • Immunophenotyping
  • Injections, Subcutaneous
  • Macaca mulatta
  • Male
  • Organophosphonates (administration & dosage)
  • Simian Acquired Immunodeficiency Syndrome (drug therapy, immunology)
  • T-Lymphocyte Subsets (immunology)
  • Tenofovir

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: